赛尼哌(抗Tac单抗注射液),适应症为本品为免疫抑制剂,适用于预防肾移植后急性排斥反应的发生,它可与包含环孢素和皮质类固醇激素的免疫抑制方案一起使用。
结论:赛尼哌用于肾移植的免疫诱导治疗,可以预防和减少急性排斥反应的发生,安全性和耐受性好。
CONCLUSION: Zenapax used for immunity induction of renal transplantation can prevent and reduce the occurrence of acute reject reaction, it has safety and good tolerance.
在过敏反应、细胞因子释放综合征、神经系统症状、感染等方面,赛尼哌组发生率明显低于OKT3组(P< 0 .0 5 )。
The incidence of allergy cytokine release syndrome and infection in Zenapax group were significantly lower than in OKT3 group ( P< 0.05 ).
应用推荐